Data / Form D filings / DNA SEQ 2, INC.
DNA SEQ 2, INC.: Form D filing
DNA SEQ 2, INC., a pharmaceuticals company in Vista, CA, filed a Form D with the SEC in 2026. The latest, on March 11, 2026, reports $1.2 million sold of a $1.2 million offering to 32 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1255 E VISTA WAY #157, Vista, CA, 92084
- Phone
- (585) 987-2800
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2115201
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | New notice | $1,176,300 | $1,176,300 | 32 | Apr 10, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Nappin | Executive Officer | |
| Stuart E. Siegel | Director | |
| Janusz Maria Sowadski | Director | |
| Eric Ladizinsky | Director | |
| Thomas M. Wheeler | Director | |
| Benjamin Anderson | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Mar 9, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DNA SEQ 2, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.